163 related articles for article (PubMed ID: 38791546)
21. Lysophosphatidic acid signaling through LPA receptor subtype 1 induces colony scattering of gastrointestinal cancer cells.
Shin KJ; Kim YL; Lee S; Kim DK; Ahn C; Chung J; Seong JY; Hwang JI
J Cancer Res Clin Oncol; 2009 Jan; 135(1):45-52. PubMed ID: 18592268
[TBL] [Abstract][Full Text] [Related]
22. Dual mode regulation of migration by lysophosphatidic acid in human gastric cancer cells.
Shida D; Kitayama J; Yamaguchi H; Hama K; Aoki J; Arai H; Yamashita H; Mori K; Sako A; Konishi T; Watanabe T; Sakai T; Suzuki R; Ohta H; Takuwa Y; Nagawa H
Exp Cell Res; 2004 Dec; 301(2):168-78. PubMed ID: 15530853
[TBL] [Abstract][Full Text] [Related]
23. Dioleoyl phosphatidic acid increases intracellular Ca2+ through endogenous LPA receptors in C6 glioma and L2071 fibroblasts.
Chang YJ; Kim YL; Lee YK; Sacket SJ; Kim K; Kim HL; Han M; Bae YS; Okajima F; Im DS
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):268-76. PubMed ID: 17499746
[TBL] [Abstract][Full Text] [Related]
24. Different mechanisms regulate lysophosphatidic acid (LPA)-dependent versus phorbol ester-dependent internalization of the LPA1 receptor.
Urs NM; Kowalczyk AP; Radhakrishna H
J Biol Chem; 2008 Feb; 283(9):5249-57. PubMed ID: 18089565
[TBL] [Abstract][Full Text] [Related]
25. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain.
Ma L; Uchida H; Nagai J; Inoue M; Chun J; Aoki J; Ueda H
Mol Pain; 2009 Nov; 5():64. PubMed ID: 19912636
[TBL] [Abstract][Full Text] [Related]
26. The LPA
Solís KH; Romero-Ávila MT; Guzmán-Silva A; García-Sáinz JA
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201414
[TBL] [Abstract][Full Text] [Related]
27. Lysophosphatidic acid signaling via LPA
Fukushima K; Takahashi K; Yamasaki E; Onishi Y; Fukushima N; Honoki K; Tsujiuchi T
Exp Cell Res; 2017 Mar; 352(1):139-145. PubMed ID: 28189636
[TBL] [Abstract][Full Text] [Related]
28. Lysophosphatidic Acid Inhibits Insulin Signaling in Primary Rat Hepatocytes via the LPA3 Receptor Subtype and is Increased in Obesity.
Fayyaz S; Japtok L; Schumacher F; Wigger D; Schulz TJ; Haubold K; Gulbins E; Völler H; Kleuser B
Cell Physiol Biochem; 2017; 43(2):445-456. PubMed ID: 28922661
[TBL] [Abstract][Full Text] [Related]
29. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells.
Yu S; Murph MM; Lu Y; Liu S; Hall HS; Liu J; Stephens C; Fang X; Mills GB
J Natl Cancer Inst; 2008 Nov; 100(22):1630-42. PubMed ID: 19001604
[TBL] [Abstract][Full Text] [Related]
30. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
Chen M; Towers LN; O'Connor KL
Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
[TBL] [Abstract][Full Text] [Related]
31. Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor.
Hasegawa Y; Erickson JR; Goddard GJ; Yu S; Liu S; Cheng KW; Eder A; Bandoh K; Aoki J; Jarosz R; Schrier AD; Lynch KR; Mills GB; Fang X
J Biol Chem; 2003 Apr; 278(14):11962-9. PubMed ID: 12554733
[TBL] [Abstract][Full Text] [Related]
32. Functional characterization of lysophosphatidic acid receptor 1 mutants identified in rat cancer tissues.
Ishii S; Tsujiuchi T; Fukushima N
Biochem Biophys Res Commun; 2017 May; 486(3):767-773. PubMed ID: 28342860
[TBL] [Abstract][Full Text] [Related]
33. Lysophosphatidic acid stimulates prostaglandin E2 production in cultured stromal endometrial cells through LPA1 receptor.
Woclawek-Potocka I; Kondraciuk K; Skarzynski DJ
Exp Biol Med (Maywood); 2009 Aug; 234(8):986-93. PubMed ID: 19491366
[TBL] [Abstract][Full Text] [Related]
34. Lysophosphatidic Acid Receptor 1- and 3-Mediated Hyperalgesia and Hypoalgesia in Diabetic Neuropathic Pain Models in Mice.
Ueda H; Neyama H; Matsushita Y
Cells; 2020 Aug; 9(8):. PubMed ID: 32824296
[TBL] [Abstract][Full Text] [Related]
35. Lysophosphatidic acid acts on LPA
Chabowski DS; Kadlec AO; Ait-Aissa K; Hockenberry JC; Pearson PJ; Beyer AM; Gutterman DD
Br J Pharmacol; 2018 Nov; 175(22):4266-4280. PubMed ID: 30153326
[TBL] [Abstract][Full Text] [Related]
36. Reciprocal regulation of miR-23a and lysophosphatidic acid receptor signaling in cardiomyocyte hypertrophy.
Yang J; Nie Y; Wang F; Hou J; Cong X; Hu S; Chen X
Biochim Biophys Acta; 2013 Aug; 1831(8):1386-94. PubMed ID: 23711961
[TBL] [Abstract][Full Text] [Related]
37. The role of lysophosphatidic acid receptors in phenotypic modulation of vascular smooth muscle cells.
Zhou Z; Niu J; Zhang Z
Mol Biol Rep; 2010 Jul; 37(6):2675-86. PubMed ID: 19757175
[TBL] [Abstract][Full Text] [Related]
38. Lysophosphatidic acid receptor LPA
Chen WM; Chiang JC; Lin YC; Lin YN; Chuang PY; Chang YC; Chen CC; Wu KY; Hsieh JC; Chen SK; Huang WP; Chen BPC; Lee H
Aging Cell; 2020 Jan; 19(1):e13064. PubMed ID: 31714004
[TBL] [Abstract][Full Text] [Related]
39. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq.
Kim J; Keys JR; Eckhart AD
Cell Signal; 2006 Oct; 18(10):1695-701. PubMed ID: 16504475
[TBL] [Abstract][Full Text] [Related]
40. Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis.
David M; Ribeiro J; Descotes F; Serre CM; Barbier M; Murone M; Clézardin P; Peyruchaud O
Int J Oncol; 2012 Apr; 40(4):1133-41. PubMed ID: 22200658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
